FibroBiologics Files 2024 10-K

Ticker: FBLG · Form: 10-K · Filed: Mar 31, 2025 · CIK: 1958777

Fibrobiologics, INC. 10-K Filing Summary
FieldDetail
CompanyFibrobiologics, INC. (FBLG)
Form Type10-K
Filed DateMar 31, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-K, annual-report, pharmaceuticals

TL;DR

FibroBiologics dropped its 2024 10-K. Check financials and strategy.

AI Summary

FibroBiologics, Inc. filed its 2024 10-K on March 31, 2025, reporting on its fiscal year ending December 31, 2024. The company, located in Houston, TX, operates in the Pharmaceutical Preparations sector. Key financial details and strategic information are presented in this comprehensive annual report.

Why It Matters

This filing provides investors and stakeholders with a detailed overview of FibroBiologics' financial performance, operational activities, and risk factors for the fiscal year 2024.

Risk Assessment

Risk Level: medium — As a pharmaceutical company, FibroBiologics faces inherent risks related to drug development, regulatory approvals, and market competition.

Key Numbers

Key Players & Entities

FAQ

What is FibroBiologics, Inc.'s primary business activity?

FibroBiologics, Inc. is classified under Standard Industrial Classification code 2834, which pertains to Pharmaceutical Preparations.

When did FibroBiologics, Inc. file its 10-K report?

The 10-K report was filed on March 31, 2025.

What fiscal year does this 10-K filing cover?

This 10-K filing covers the fiscal year ending on December 31, 2024.

Where is FibroBiologics, Inc. located?

FibroBiologics, Inc. is located at 455 E. Medical Center Blvd, Suite 300, Houston, TX 77598.

What is the SEC file number for FibroBiologics, Inc.'s 10-K?

The SEC file number for this 10-K filing is 001-41934.

Filing Details

This Form 10-K (Form 10-K) was filed with the SEC on March 31, 2025 regarding FibroBiologics, Inc. (FBLG).

View full filing on EDGAR

View Full Filing

View this 10-K filing on SEC EDGAR

View on Read The Filing